Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated with AZD1222

Trial Identifier:	D8111R00003
Sponsor:	AstraZeneca
NCTID::	NCT04877743
Start Date:	May 2021
Primary Completion Date:	November 2021
Study Completion Date:	November 2021

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Essen, Germany, 45355

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.